Advanced search
Publication Cover
Pharmacogenomics and Personalized Medicine Volume 10, 2017 - Issue
Submit an article Journal homepage
96
Views
0
CrossRef citations to date
0
Altmetric
Letter

Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the UGT1A1*28 allele

Anushka Naidoo1 Centre for the AIDS Programme of Research in South AfricaCorrespondence[email protected]
,
Kogieleum Naidoo1 Centre for the AIDS Programme of Research in South Africa;2 MRC-CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Doris Duke Medical Research Institute
,
Veron Ramsuran3 School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa
,
Millidhashni Reddy1 Centre for the AIDS Programme of Research in South Africa
&
Nesri Padayatchi1 Centre for the AIDS Programme of Research in South Africa;2 MRC-CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Doris Duke Medical Research Institute
Pages 233-234 | Published online: 23 Aug 2017
 
"Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the UGT1A1*28 allele." Pharmacogenomics and Personalized Medicine, , pp. 233–234

Disclosure

The authors report no conflicts of interest in this co m munication.

Download PDF

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.